Advances in reducing cardiovascular risk in the management of patients with type 2 diabetes mellitus
Treatment intended to lower cardiovascular (CV) risk in patients with diabetes has always been a primary goal of diabetes treatment. Due to the subdued effects of reducing hemoglobin A1c (HbA1c) on macrovascular complications, controlling other CV risk factors such as hypertension and hyperlipidemia...
Enregistré dans:
| Auteur principal: | |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
KeAi Communications Co., Ltd.
2019
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/629f46516f7f4dd2a8f15300457c6d7d |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|